Fig 1.
Trial profile: Consort flow diagram.
Abbreviations: mEHT: Modulated Electro-Hyperthermia; LDFS: Local Disease Free Survival.
Table 1.
Participant and treatment characteristics.
Table 2.
Treatment characteristics.
Table 3.
Result of Multivariate logistic regression model to predict LDC (adjusted for HIV status, age, and stage).
Table 4.
Result of logistic regression analysis to predict six month LDFS (adjusted for HIV status, age, and stage).
Fig 2.
Tumour Response as Seen on 18F-FDG PET/CT (PERCIST 1.0) by Treatment Group.
mEHT: Fischer’s exact table of association between all four metabolic responses and mEHT: p = 0.005*. Abbreviations: mEHT: Modulated electro-hyperthermia; CMR: Complete Metabolic Response; PMR: Partial Metabolic Response; SMD: Stable Metabolic Disease; PMD: Progressed Metabolic Disease.
Fig 3.
Tumour Response on 18F-FDG PET/CT (PERCIST 1.0) by Treatment Group and HIV Status.
Total participants in each subgroup: HIV-Positive mEHT: n = 40; HIV-Positive Control: n = 35; HIV-Negative mEHT: n = 45; HIV-Negative Control: n = 38. Abbreviations: mEHT: Modulated electro-hyperthermia.
Table 5.
Number of patients with nodes visualized in each region on pre-treatment scans.